Sonia completed her undergraduate and graduate studies in Spain. She identified new mutations in genes causing autosomal dominant polycystic kidney disease present only in Spanish families. Upon graduation she moved to Yale University and led the identification of two human genes causing Polycystic Liver Disease (PLD).

In 2004 Sonia joined the Genome Institute of Singapore as a postdoctoral fellow on nephrogenomics. She was rapidly promoted to Research Scientist and to Principal Investigator. Her work focused on human genetic susceptibility to infectious diseases. She has identified genetic mutations involved in immune-related diseases, infectious and autoimmune disorders, rare diseases like Kawasaki and meningococcal disease among others.

In 2016 she started working at SingHealth-Duke NUS AMC to work on clinical implementation of nprecisioonb medicine. She was Deputy Director of SingHealth Duke-NUS Institute of Precision Medicine (PRISM) and Director of Research at the SingHealth Duke-NUS Genomic Medicine Centre.

Sonia joined Sidra Medicine in December 2023 as Executive Director -Translational Medicine.

Sonia Davila is contributing to the advancement of genomic medicine and precision medicine as a practical clinical tool capable of benefitting patients across the globe—no matter how rare their disease.